Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1052 U.S. listed China Stocks and Counting...
 Tracking 1535 U.S. Stocks and Counting...

 Bohai Pharmaceuticals (OTC BB:BOPH)

Tuesday, July 13, 2010

Effective July 12, 2010, the board of directors (consisting of Hongwei Qu, the sole director) of Bohai Pharmaceuticals Group, Inc. (the “Company”), by written consent to action and pursuant to the Company’s Amended and Restated Bylaws (which provides for a classified board of directors of the Company), appointed the following persons to serve on the board of directors of the Company

  • Wang Chengde  and Hongwei Qu (for terms ending with the 2010 annual meeting of stockholders)
  •   Louis A. Bevilacqua, Esq. (for a term ending with the 2011 annual meeting of stockholders)
  •    Adam Wasserman (for a term ending with the 2012 annual meeting of stockholders)